<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">
<html><body><html><body><section class="summaryOfFindings"><div class="section-header section-collapse-header" id="CD004714-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"><div class="section-header" id="CD004714-sec-0008"></div> <div class="table" id="CD004714-tbl-0001"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 1.</span> <span class="table-title">Periodontal treatment compared to no treatment/usual care for glycaemic control in people with diabetes mellitus</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<th scope="col" align="" valign="" colspan="6" rowspan="1" class="headercell"> <p><b>Periodontal treatment versus no active treatment/usual care</b><b>for glycaemic control in people with diabetes mellitus</b> </p> </th> </tr>
<tr class="separated">
<td align="" valign="" colspan="6" rowspan="1" bgcolor="#ffffff"> <p><b>Population:</b> people with diabetes mellitus and periodontitis<br><b>Settings:</b> hospital, primary care, community<br><b>Intervention:</b> periodontal treatment<br><b>Comparison:</b> no active treatment/usual care </p> </td> </tr>
<tr class="separated">
<th scope="col" align="" valign="" colspan="1" rowspan="3" class="headercell"> <p><b>Outcomes</b> </p> </th> <th scope="col" align="" valign="" colspan="2" rowspan="1" class="headercell table-tint"> <p><b>Illustrative comparative risks<sup>*</sup> (95% CI)</b> </p> </th> <th scope="col" align="" valign="" colspan="1" rowspan="3" class="headercell"> <p><b>Number of participants<br>(studies)</b> </p> </th> <th scope="col" align="" valign="" colspan="1" rowspan="3" class="headercell"> <p><b>Certainty of the evidence<br>(GRADE)</b> </p> </th> <th scope="col" align="" valign="" colspan="1" rowspan="3" class="headercell"> <p><b>Comments</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="" valign="" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Assumed risk</b> </p> </th> <th scope="col" align="" valign="" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Corresponding risk</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="" valign="" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Usual care/no active treatment</b> </p> </th> <th scope="col" align="" valign="" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Periodontal treatment</b> </p> </th> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>HbA1c </b><br>Follow‐up: 3 to 4 months </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The median HbA1c at 3 to 4 months follow‐up was 7.74%</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean HbA1c in the periodontal treatment groups was <b>0.43 percentage points lower</b> (95% CI 0.28 to 0.59 lower)<sup>c</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2443<br>(30 studies (4 with multiple arms)) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊕⊝<br><b>MODERATE</b><sup>a,b</sup></p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Periodontal treatment probably improves glycaemic control as measured by HbA1c at 3 to 4 months follow‐up. Results in favour of periodontal treatment were also found at 6 and 12 months (6 months: ‐0.30%, 95% CI ‐0.52% to ‐0.08%; I<sup>2</sup> = 80%; 12 studies, 1457 participants; 12 months: ‐0.50%, 95% CI ‐0.55% to ‐0.45%; 1 study, 264 participants)<sup>d</sup></p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse effects</b> </p> </td> <td align="" valign="" colspan="5" rowspan="1" class="table-tint table-highlight"> <p>Insufficient evidence to determine whether SRP for glycaemic control is associated with any harms. Most studies did not evaluate adverse effects  </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="6" rowspan="1" bgcolor="#ffffff"> <p><sup>*</sup>The <b>assumed risk</b> is the mean control group risk across studies. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br><b>CI:</b> confidence interval; <b>HbA1c:</b> glycated haemoglobin; <b>mmol/mol:</b> millimoles per mole; <b>SRP:</b> scaling and root planing </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="6" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br><b>Low certainty: </b>our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>Downgraded 1 level for high risk of bias, largely due to lack of blinding.<br><sup>b</sup>Not downgraded for moderate heterogeneity (I<sup>2</sup> = 70%) at 3 to 4 months because of similar effects seen across all time periods.<br><sup>c</sup>Mmol/mol equivalent: 4.7 mmol/mol lower in the intervention group than the control group after 3 to 4 months (95% CI ‐6.4 to ‐3.0).<br><sup>d</sup>Mmol/mol equivalents: 3.3 mmol/mol lower in the intervention group than the control group after 6 months (95% CI ‐5.7 to ‐0.9), and 5.4 mmol/mol lower in the intervention group than the control group after 12 months (95% CI  ‐6.0 to ‐4.9). </p> </div> </td> </tr></tfoot>
</table>
</div> </section></section></body></html></body></html>
